Clinical Trial Update: The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia [Phase 3]

View source ↗

Summary

This clinical trial update reports the efficacy and safety results of risperidone in adolescents with schizophrenia in a Phase 3 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED